The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Measuring, Analyzing, and Managing Drug Adherence in Resistant Hypertension
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertensive patients were shown to take their medication more frequently 1–3 days before their clinic appointment[31].”
From Adherence is associated with a favorable outcome after lung transplantation (2019) · cites this paper as [31]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Self-citation2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
A new taxonomy for describing and defining adherence to medications
Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04167.x · Cited by 2,028
Self-citationMancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f0580f · Cited by 1,837
Self-citationA meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
Cushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979
Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., & Burnier, M. (2008) · BMJ · doi:10.1136/bmj.39553.670231.25 · Cited by 865
Self-citationAdherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients
Naderi, S. H., Bestwick, J. P., & Wald, D. S. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.12.013 · Cited by 863
de la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168948 · Cited by 809
Prevalence of Resistant Hypertension in the United States, 2003–2008
Persell, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.170308 · Cited by 761
Mazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., Borghi, C., Brignoli, O., Caputi, A. P., Cricelli, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.830299 · Cited by 637
Interventions for enhancing medication adherence
Haynes, R. B., Yao, X., Degani, A., Kripalani, S. B., Garg, A. X., & McDonald, H. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub2 · Cited by 512
Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
Chapman, R. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1147 · Cited by 506
Granger, B. B., Swedberg, K. B., Ekman, I., Granger, C. B., Olofsson, B., McMurray, J. J. V., Yusuf, S., Michelson, E. L., & Pfeffer, M. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67760-4 · Cited by 475
Resistant hypertension? Assessment of adherence by toxicological urine analysis
Jung, O., Gechter, J. L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., & Toennes, S. W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835e2286 · Cited by 474
Patient Compliance in Medical Practice and Clinical Trials
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-582_3 · Cited by 465
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension
Esler, M., Krum, H., Schlaich, M. P., Schmieder, R. E., Böhm, M., & Sobotka, P. A. (2012) · Circulation · doi:10.1161/circulationaha.112.130880 · Cited by 462
Blaschke, T. F., Osterberg, L. G., Vrijens, B., & Urquhart, J. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011711-113247 · Cited by 420
Self-citationCompliance Declines Between Clinic Visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390190143023 · Cited by 384
Better compliance to antihypertensive medications reduces cardiovascular risk
Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328342ca97 · Cited by 367
Novel Baroreflex Activation Therapy in Resistant Hypertension
Scheffers, I. J. M., Kroon, A. A., Schmidli, J., Jordan, J., Tordoir, J. H. M., Mohaupt, M. G., Luft, F. C., Haller, H. G., Menne, J., Engeli, S., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.089 · Cited by 356
Compliance with Topical Pilocarpine Treatment
Kass, M. A., Meltzer, D. W., Gordon, M. O., Cooper, D. G., & Goldberg, J. J. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90939-6 · Cited by 342
Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors
Santschi, V. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.399 · Cited by 309
Jaime, J., Speckman, J. L., Salas, M., Raggio, G., & Jackson, J. D. (1999) · Europe PMC (PubMed Central) · Cited by 272
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts
Nachega, J. B., Marconi, V. C., van Zyl, G. U., Gardner, E. M., Preiser, W., Hong, S. Y., Mills, E. J., & Gross, R. (2011) · Infectious Disorders - Drug Targets · doi:10.2174/187152611795589663 · Cited by 271
Burnier, M., Schneider, M. P., Chioléro, A., Stubi, C.-L. F., & Brunner, H. R. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00022 · Cited by 264
Self-citationTime to stop counting the tablets?
Pullar, T., Kumar, S., Tindall, H., & Feely, M. (1989) · Clinical pharmacology and therapy · doi:10.1038/clpt.1989.121 · Cited by 251
On White-Coat Effects and the Electronic Monitoring of Compliance
Feinstein, A. R. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390190043003 · Cited by 236
Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs
Dragomir, A., Côté, R., Roy, L., Blais, L., Lalonde, L., Bérard, A., & Perreault, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181d567bd · Cited by 221
Impact of pharmacist care in the management of cardiovascular disease risk factors
(2012) · Clinical Governance An International Journal · doi:10.1108/cgij.2012.24817aaa.011 · Cited by 212
Cm, D. (2000) · PubMed · Cited by 211
Facts and fiction of poor compliance as a cause of inadequate blood pressure control
Wetzels, G., Nelemans, P. J., Schouten, J., & Prins, M. H. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00002 · Cited by 172
Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
Belknap, R., Weis, S., Brookens, A., Au-Yeung, K. Y., Moon, G., DiCarlo, L., & Reves, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053373 · Cited by 160
Myat, A., Redwood, S. R., Qureshi Ayesha, C., Spertus, J. A., Williams, B., Liu, X., & 杜昕 (2013) · doi:10.1136/bmj.j.issn.1007-9742.2013.16.140 · Cited by 158
Adherence to the Therapeutic Regimen in Heart, Lung, and Heart-Lung Transplant Recipients
Geest, S. D., Dobbels, F., Fluri, C., Paris, W. D., & Troosters, T. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200509001-00010 · Cited by 157
Adherence and persistence with taking medication to control high blood pressure
Hill, M. N., Miller, N. H., & Geest, S. D. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.01.001 · Cited by 154
Toczek, A., Cox, H. S., du Cros, P., Cooke, G., & Ford, N. P. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0537 · Cited by 133
Daily regimen and compliance with treatment
Bloom, B. S. (2001) · BMJ · doi:10.1136/bmj.323.7314.647 · Cited by 127
Antihypertensive Medication Adherence, Ambulatory Visits, and Risk of Stroke and Death
Bailey, J. E., Wan, J. Y., Tang, J., Ghani, M. A., & Cushman, W. C. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1240-1 · Cited by 120
Nüesch, R., Schroeder, K., Dieterle, T., Martina, B., & Battegay, E. J. (2001) · BMJ · doi:10.1136/bmj.323.7305.142 · Cited by 120
Pladevall, M., Brotons, C., Gabriel, R., Arnau, A., Suárez, C., de la Figuera, M., Marquez, E., Coca, A., Sobrino, J., Divine, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.892778 · Cited by 109
Daugherty, S. L., Powers, J. D., Magid, D. J., Masoudi, F. A., Margolis, K. L., O’Connor, P. J., Schmittdiel, J. A., & Ho, P. M. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.192096 · Cited by 109
Understanding contraceptive failure
Trussell, J. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.11.008 · Cited by 106
Fagard, R. H. (2011) · Heart · doi:10.1136/heartjnl-2011-300741 · Cited by 104
Improving on a Coin Toss To Predict Patient Adherence to Medications
Turner, B. J., & Hecht, F. M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00015 · Cited by 97
Persistence with Treatment in Newly Treated Middle-Aged Patients with Essential Hypertension
Perreault, S. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e548 · Cited by 91
Monitoring compliance in resistant hypertension: an important step in patient management
Burnier, M., Santschi, V., Favrat, B., & Brunner, H. R. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305002-00007 · Cited by 91
Self-citationVrijens, B., Tousset, E., Rode, R. A., Bertz, R., Mayer, S., & Urquhart, J. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004274433 · Cited by 91
Self-citationChristensen, A., Osterberg, L. G., & Hansen, E. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832d50ef · Cited by 84
Prevalence and Correlates of Low Medication Adherence in Apparent Treatment‐Resistant Hypertension
Irvin, M. R., Shimbo, D., Mann, D. M., Reynolds, K., Krousel-Wood, M. A., Limdi, N. A., Lackland, D. T., Calhoun, D. A., Oparil, S., & Muntner, P. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00690.x · Cited by 80
Understanding Forgiveness: Minding and Mining the Gaps Between Pharmacokinetics and Therapeutics
Osterberg, L. G., Urquhart, J., & Blaschke, T. F. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.171 · Cited by 78
Self-citationZeng, F., Patel, B. V., Andrews, L., Frech‐Tamas, F., & Rudolph, A. E. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.534129 · Cited by 73
Wetzels, G., Nelemans, P. J., Schouten, J., Dirksen, C. D., VANDERWEIJDEN, T., Stoffers, J., Janknegt, R., DELEEUW, P., & Prins, M. H. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.07.018 · Cited by 63
Monitoring Compliance with Pilocarpine Therapy
Norell, S. E. (1981) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74670-7 · Cited by 59
Prediction of Diltiazem Plasma Concentration Curves From Limited Measurements Using Compliance Data
Rubio, A. I., Cox, C., & WEINTRAUB, M. I. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199222030-00006 · Cited by 58
Savić, R. M., Barrail‐Tran, A., Duval, X., Nembot, G., Panhard, X., Descamps, D., Verstuyft, C., Vrijens, B., Taburet, A. M., Goujard, C., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.137 · Cited by 49
Issues in blood pressure control and the potential role of single-pill combination therapies
Burnier, M., Brown, R. E., Ong, S. H., Keskinaslan, A., & Khan, Z. M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.01999.x · Cited by 48
Self-citationZapata, L. B., Steenland, M. W., Brahmi, D., Marchbanks, P. A., & Curtis, K. M. (2012) · Contraception · doi:10.1016/j.contraception.2012.08.035 · Cited by 44
Chapman, R. H., KOWAL, S. L., Cherry, S. B., Ferrufino, C. P., Roberts, C. S., & Chen, L. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00774.x · Cited by 43
Comté, L., Vrijens, B., Tousset, E., Gérard, P., & Urquhart, J. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9058-0 · Cited by 41
Self-citationPersistence with hypertension treatment among community-dwelling BC seniors.
Morgan, S. G., & Yan, L. (2004) · PubMed · Cited by 40
Success and failure of vaccines against renin–angiotensin system components
Brown, M. J. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.156 · Cited by 35
Renal dopamine receptors and hypertension
Ferro, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00010 · Cited by 30
Zapata, L. B., Steenland, M. W., Brahmi, D., Marchbanks, P. A., & Curtis, K. M. (2012) · Contraception · doi:10.1016/j.contraception.2012.08.026 · Cited by 28
Burnier, M., Brede, Y., & Lowy, A. J. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02616.x · Cited by 28
Self-citationThompson, C., & Tsiperfal, A. (2005) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2005.04028.x · Cited by 14
Therapierefraktäre Hypertonie - Stellenwert von elektronischem „Compliance-Monitoring”
Baulmann, J., Düsing, R., Vetter, H., & Mengden, T. (2002) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2002-35355 · Cited by 9
Research works printed but not linked: 1
- Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005;CD000011.
Cited by
Sorted by citations
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Self-citationDiretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,389
Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D. E., Chirinos, J. A., Damasceno, A. A. M., Delles, C., Gimenez‐Roqueplo, A., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 970
Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management
Burnier, M., & Egan, B. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313220 · Cited by 878
Self-citation
Metadata
- Authors
- Burnier, M., Wuerzner, G., Struijker-Boudier, H., & Urquhart, J.
- Affiliations
- University of California, San Francisco (US)
- From the Service of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland (M.B., G.W.); Department of Pharmacology, Maastricht University, Maastricht, The Netherlands (H.S.-B.); AARDEX Group, S.A., Sion, Switzerland (J.U.); and Department of Bioengineering and Therapeutic Sciences, UCSF, San Francisco, CA (J.U.).
- Venue
- Hypertension
- Published
- 2013-08
- Volume
- 62
- Issue
- 2
- Pages
- 218-225
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2160830297
- Cited by
- 229
- References
- 71
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 14 · 2022: 12 · 2021: 23 · 2020: 16 · 2019: 25 · 2018: 16 · 2017: 21 · 2016: 29 · 2015: 26 · 2014: 22 · 2013: 10
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- medication adherence, resistant hypertension, antihypertensive therapy
- MeSH terms
- Antihypertensive Agents, Humans, Hypertension, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
